1
Enquiry period
with 25.07.2024 17:15
to 05.08.2024 14:00
2
Bidding period
with 05.08.2024 14:00
to 12.08.2024 14:00
3
Auction
with 13.08.2024 14:00
to 13.08.2024 14:51
4
Evaluation

5
Contract

Status Evaluation
Estimated value without VAT 3 496 339,06 MDL
Period of clarifications: 25 Jul 2024, 17:15 - 5 Aug 2024, 14:00
Submission of proposals: 5 Aug 2024, 14:00 - 12 Aug 2024, 14:00

Supplier technical support:

(+373) 79999801

“Achiziționarea medicamentelor oncologice necesare IMSP Institutul Oncologic (suplimentar), pentru anul 2024, repetat 3”

Information about customer
Fiscal code/IDNO
Address
MD-2005, MOLDOVA, mun.Chişinău, locality, mun. Chișinău MD-2005, bd. Grigore Vieru, 22/2
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
25 Jul 2024, 16:59
Date modified
25 Jul 2024, 17:15
Achizitii.md ID
21262900
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 1 - Pemetrexedum 500 mg
Budget: 362432.64 MDL
Active
Lot nr. 2 - Pemetrexedum 100 mg
Budget: 613394.92 MDL
Active
Lot nr. 4 - Lenalidomidum 25 mg
Budget: 859692.81 MDL
Active
Documents of the procurement procedure
Propunerea financiară
Bidding Documents
Propunerea financiară
25.07.24 17:15
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
25.07.24 17:15
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
25.07.24 17:15
DUAE Model
Bidding Documents
DUAE Model
25.07.24 17:15
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
25.07.24 17:15
Anunt de participare.signed
Bidding Documents
Anunt de participare.signed
25.07.24 17:15
Model de contract
Bidding Documents
Model de contract
25.07.24 17:15
Propunerea tehnică
Bidding Documents
Propunerea tehnică
25.07.24 17:15
Documentatia standard.signed
Bidding Documents
Documentatia standard.signed
25.07.24 17:15
Only authorized platform users may ask questions during the clarification period.